Biogen Inc (BIIB)
Industry Drug Manufacturers - General
This stock can be held in an Investment ISA and an Investment Account
Sell
$118.10
Buy
$120.00
$-0.22 (-0.19%)
Biogen Inc is a biopharmaceutical company. It is engaged in discovering, developing, manufacturing and delivering therapies to patients for the treatment of neurological, rare and autoimmune diseases.
Prices updated at 10 May 2025, 00:11 EDT
| Prices minimum 15 mins delay
|
Prices in USD
Important documents: Please ensure that you have read the Pre-sale Illustrations document & Doing Business with Fidelity document (incorporating the Fidelity Client Terms) and
- Key stats
- Price
- Fair value
- Dividends
- News
- Financials
- Valuation
- Profile
Sector
Healthcare
Industry
Drug Manufacturers - General
Chairman
Ms. Caroline D. Dorsa
CEO
Mr. Christopher A. Viehbacher
Most recent earnings
31 Dec 2024
Fiscal year end
31 Dec 2024
Employees
7,605
Head office
225 Binney Street
Cambridge
United States
02142
Key personnel
| Owner name | Salary | Bonus | All other compensation | Total compensation | Restricted stock award |
|---|---|---|---|---|---|
Mr. Sean Godbout Vice President, Chief Accounting Officer & Global Corporate Controller | - | - | - | - | - |
Ms. Caroline D. Dorsa Chairman of the Board | 0.23m | - | - | 0.63m | - |
Dr. Eric K. Rowinsky,M.D. Independent Director | 0.16m | - | - | 0.46m | - |
Mr. William A. Hawkins, III Independent Director | 0.17m | - | - | 0.47m | - |
Dr. Stephen A. Sherwin, M.D. Independent Director | 0.14m | - | - | 0.44m | - |
Mr. Christopher A. Viehbacher Director, President and Chief Executive Officer | 1.60m | - | - | 24.17m | - |
Ms. Susan H. Alexander Executive Vice President and Chief Legal Officer | 0.95m | - | - | 6.51m | - |
Dr. Ginger Gregory, PhD Executive Vice President and Chief Human Resources Officer | - | - | - | - | - |
Dr. Maria C. Freire, PhD Independent Director | 0.14m | - | - | 0.44m | - |
Professor Menelas Pangalos, PhD Independent Director | - | - | - | - | - |
Ms. Robin C. Kramer Chief Financial Officer | - | - | - | - | - |
Dr. Priya Singhal, M.D.,M.P.H. Executive Vice President and Head of Development | 0.82m | - | - | 6.39m | - |
Mr. Jesus B. Mantas Independent Director | 0.17m | - | - | 0.47m | - |
Mr. Monish D. Patolawala Independent Director | 0.14m | - | - | 0.44m | - |
Dr. Jane Grogan, PhD Executive Vice President, Head of Research | - | - | - | - | - |
Mr. Rachid Izzar Executive Vice President, Global Product Strategy and Commercialization | - | - | - | - | - |
Ms. Nicole Murphy Executive Vice President, Pharmaceutical Operations and Technology | 0.76m | - | - | 5.74m | - |
Mr. Adam Keeney, PhD Executive Vice President and Head of Corporate Development | - | - | - | - | - |
Ms. Susan K. Langer Independent Director | 0.13m | - | - | 0.43m | - |
Dr. Lloyd Minor, M.D. Independent Director | 0.03m | - | - | 0.03m | - |
Top 5 shareholders
| Owner name | No. of shares | Share as % of port. | Last change | Portfolio % change | Date of portfolio | % Total assets |
|---|---|---|---|---|---|---|
| Vanguard Group Inc. ( Junked) | 16,677,806 | - | 16677806 | - | 30 Apr 2025 | 11.45 |
| Vanguard Group Inc | 16,748,875 | 0.04461 | 70368 | 0.421908 | 30 Apr 2025 | 11.43 |
| PRIMECAP Management Company | 16,046,209 | 1.9004 | -268870 | -1.647985 | 30 Apr 2025 | 10.95 |
| BlackRock Inc | 15,473,710 | 0.04788 | 126669 | 0.825364 | 30 Apr 2025 | 10.56 |
| Vanguard PrimeCap Fund | 9,009,361 | 1.72129 | -86360 | -0.949457 | 30 Apr 2025 | 6.15 |
Director dealings
| Date | Action | Name | Price | Value | No. of shares | Holding (%) | Additional info |
|---|---|---|---|---|---|---|---|
| 06 Dec 2024 | - | Ms. Robin C. Kramer | 157.78 | 26,823 | 6,408 | - | - |
| 06 Dec 2024 | - | Ms. Robin C. Kramer | - | - | 6,578 | - | - |
| 06 Dec 2024 | - | Ms. Robin C. Kramer | - | - | - | - | - |
| 06 Dec 2024 | - | Dr. Priya Singhal, M.D.,M.P.H. | - | - | - | - | - |
| 06 Dec 2024 | - | Dr. Priya Singhal, M.D.,M.P.H. | 157.78 | 32,503 | 5,536 | - | - |
| 06 Dec 2024 | - | Dr. Priya Singhal, M.D.,M.P.H. | - | - | 5,742 | - | - |
| 09 Dec 2024 | - | Dr. Priya Singhal, M.D.,M.P.H. | 157.21 | 17,293 | 5,426 | - | - |
| 05 Nov 2024 | - | Ms. Susan H. Alexander | - | - | 20,082 | - | - |
| 05 Nov 2024 | - | Ms. Susan H. Alexander | - | - | 31,601 | - | - |
| 01 Nov 2024 | - | Dr. Jane Grogan, PhD | - | - | 695 | - | - |
| 01 Nov 2024 | - | Dr. Jane Grogan, PhD | - | - | 1,390 | - | - |
| 01 Nov 2024 | - | Dr. Jane Grogan, PhD | 173.79 | 35,453 | 491 | - | - |
| 30 Aug 2024 | - | Dr. Priya Singhal, M.D.,M.P.H. | 204.76 | 165,241 | 5,747 | - | - |
| 30 Aug 2024 | - | Dr. Priya Singhal, M.D.,M.P.H. | - | - | 1,669 | - | - |
| 03 Sep 2024 | - | Dr. Priya Singhal, M.D.,M.P.H. | 204.22 | 88,019 | 5,316 | - | - |
| 30 Aug 2024 | - | Dr. Priya Singhal, M.D.,M.P.H. | - | - | 6,554 | - | - |
| 21 Jun 2024 | - | Ms. Caroline D. Dorsa | - | - | 26,607 | - | - |
| 21 Jun 2024 | - | Dr. Eric K. Rowinsky,M.D. | - | - | 21,969 | - | - |
| 21 Jun 2024 | - | Mr. William A. Hawkins, III | - | - | 6,490 | - | - |
| 21 Jun 2024 | - | Dr. Stephen A. Sherwin, M.D. | - | - | 20,078 | - | - |
Please note that past performance is not a reliable indicator of future returns.
